Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.

Cecilia NalliValentina SommaLaura AndreoliThomas BüttnerPeter SchierackMichael MahlerDirk RoggenbuckAngela Tincani

Published in: Auto- immunity highlights (2018)

aD1/aD4-5 (ELISA) and aPG IgG (LIA) differentiate APS from SARD patients. PG appears to interact with β2GPI of APS patients and exposes D1 thereof for disease-specific aPL binding in LIA.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
fatty acid
patient reported outcomes